Revance Therapeutics shares owned by Swiss National Bank
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Swiss National Bank
from 13F filings
Historical chart of Swiss National Bank investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Swiss National Bank
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.4M | 165k | 8.79 |
| 2023-09-30 | $2.1M | 185k | 11.47 |
| 2023-06-30 | $4.6M | 183k | 25.31 |
| 2023-03-31 | $5.7M | 178k | 32.21 |
| 2022-12-31 | $3.6M | 196k | 18.46 |
| 2022-09-30 | $5.2M | 192k | 27.00 |
| 2022-06-30 | $2.2M | 161k | 13.82 |
| 2022-03-31 | $3.1M | 161k | 19.50 |
| 2021-12-31 | $2.4M | 150k | 16.32 |
| 2021-09-30 | $4.2M | 150k | 27.86 |
| 2021-06-30 | $4.4M | 150k | 29.64 |
| 2021-03-31 | $3.8M | 137k | 27.95 |
| 2020-12-31 | $3.8M | 134k | 28.34 |
| 2020-09-30 | $2.9M | 116k | 25.14 |
| 2020-06-30 | $2.8M | 115k | 24.42 |
| 2020-03-31 | $1.3M | 90k | 14.80 |
| 2019-12-31 | $1.4M | 89k | 16.23 |
| 2019-09-30 | $954k | 73k | 13.01 |
| 2019-06-30 | $951k | 73k | 12.97 |
| 2019-03-31 | $1.1M | 70k | 15.77 |
| 2018-12-31 | $1.1M | 52k | 20.13 |
| 2018-09-30 | $1.3M | 51k | 24.86 |
| 2018-06-30 | $1.4M | 51k | 27.44 |
| 2018-03-31 | $1.6M | 51k | 30.79 |
| 2017-12-31 | $1.8M | 52k | 35.74 |
| 2017-09-30 | $977k | 36k | 27.56 |
| 2017-06-30 | $867k | 33k | 26.39 |
| 2017-03-31 | $683k | 33k | 20.79 |
| 2016-12-31 | $637k | 31k | 20.72 |
| 2016-09-30 | $498k | 31k | 16.20 |
| 2016-06-30 | $418k | 31k | 13.59 |
| 2016-03-31 | $518k | 31k | 16.85 |
| 2015-12-31 | $845k | 25k | 34.14 |
| 2015-09-30 | $620k | 21k | 29.74 |
| 2015-06-30 | $622k | 20k | 31.98 |
| 2015-03-31 | $268k | 13k | 20.69 |
| 2014-12-31 | $219k | 13k | 16.91 |
| 2014-09-30 | $204k | 11k | 19.34 |
| 2014-06-30 | $359k | 11k | 34.03 |